GV

GV is the corporate venture capital arm of Alphabet, based in the San Francisco Bay Area in the United States with offices in New York, Cambridge and London, and it invests across North America, Europe and Israel. Its technology focus covers AI-native applications, the AI infrastructure layer including photonic computing, data labeling and inference, developer tools and security, and enterprise and consumer software. In life sciences and healthcare it backs AI-driven drug discovery and other health companies, alongside a frontier technology practice for longer-horizon hardware and science bets. The firm aims to be early to new technology layers and invests from seed through growth stage, both leading and joining rounds. Beyond capital, portfolio companies get support from GV operating partners in executive recruiting, communications and marketing, plus connections to teams and resources across Google and Alphabet. The website does not publish a pitch form or a typical check size.